Q32 Bio Inc. Reports Q2 2026 Financial Results

What Happened

• On August 5, 2026, Q32 Bio Inc. announced its financial results for the quarter ended June 30, 2026 and provided a corporate update via a press release. The release is furnished as Exhibit 99.1 to the Form 8-K. The filing is furnished (not “filed”) under the Exchange Act. The report was signed by Jodie Morrison, Chief Executive Officer.

Key Details

• Date of announcement: August 5, 2026.
• Reporting period: Quarter ended June 30, 2026.
• Press release: Furnished as Exhibit 99.1 to the Form 8-K.
• Legal note: Information is furnished, not filed, and therefore not subject to Section 18 liability or automatically incorporated by reference in other SEC filings.

Why It Matters

• This 8-K signals Q32 Bio has published its latest quarterly results and a corporate update—key information investors use to assess recent earnings, revenue trends, cash position, and operational progress.
• Because the detailed financials and narrative are in the press release (Exhibit 99.1), investors should read that release and the company’s other SEC filings for specific figures (revenue, net loss/profit, cash runway, guidance) before making investment decisions.
• The “furnished, not filed” designation limits certain legal liabilities but does not change the substance of the disclosed results; the press release remains the primary source for the quarter’s metrics and any management commentary.